Open AccessEffect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
Author(s) -
Marcia S. Brose,
Francis P. Worden,
Kate Newbold,
Matthew Guo,
Arti Hurria
Publication year - 2018
Publication title -
opuholi golovy i šei
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 1
eISSN - 2411-4634
pISSN - 2222-1468
DOI - 10.17650/2222-1468-2018-8-2-39-52
Subject(s) - lenvatinib , thyroid cancer , refractory (planetary science) , medicine , oncology , safety profile , clinical trial , phase (matter) , thyroid , adverse effect , chemistry , materials science , metallurgy , organic chemistry
.